Clinical Trials Directory

Trials / Completed

CompletedNCT02695368

The Effect of Plasma-air-filtration on the Incidence of Surgical Site Infections in Orthopaedic Surgery

The Effect of Air-filtration Through a Plasma Chamber on the Incidence of Surgical Site Infections in Orthopaedic Surgery: a Double-blind, Randomized, Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45,000 (actual)
Sponsor
Karolinska Institutet · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The study is a multicenter, double-blind, randomized, controlled trial conducted at six major university and teaching hospitals with a catchment population of approximately 2 million. In the current study it has been hypothesized that a non-invasive air cleaner utilizing a plasma chamber can significantly reduce the incidence of surgical site infections (SSIs).

Detailed description

Despite operating in clean theaters, surface sterilization, and antibiotics, surgical site infections (SSI) after orthopaedic surgery have an estimated incidence of 1-4%. This feared complication is associated with long-term antibiotics, repeated surgeries, prolonged hospital stays, economic burden and a poorer end result for individual patients. It is therefore of great importance to prevent SSI.While skin bacteria and contaminated surfaces have generally been claimed to be the main cause of infections, there are estimates that approximately 20% of hospital-acquired infections are air-transmitted, making this an interesting intervention target. Novaerus is an air-cleaner that sterilizes the air particles through a plasma chamber. Air in the operating theatre is pumped through the chamber (80-380 m3/Hr) and by using a small current it transforms the gas in the vicinity of the electrode into plasmaand eradicates any bacteria that pass through.The small size of the machine allows it to fit into any operating theater without interfering with existing equipment. This technology can reduce the number of colony forming units (CFU) when in hospital settings. In non-randomized settings it has been correlated to reduced respiratory infections, reduced personnel sick-leave, and absence of severe infectious outbreaks. Its effect has not been validated in randomized controlled trials. Both local and national registry data will be used according to availability.

Conditions

Interventions

TypeNameDescription
DEVICENovaerus NV800 onThe air-cleaner sterilizes the air particles through a plasma chamber. Air in the operating theatre is pumped through the chamber (80 - 380 m3/Hr) and by using a small current it transforms the gas in the vicinity of the electrode into plasma and eradicates any bacteria that pass through. The air-cleaner has to have been turned on for at least 2 days prior to the surgical intervention.
DEVICENovaerus NV800 offThe machine decribed above is running but the plasma filter chamber isn't active, i.e. the placebo group.
DEVICENovaerus NV800 on or offPatients with multiple surgeries that have been operated during both periods when the apparatus has been on and off will belong to this mixed group.

Timeline

Start date
2017-04-10
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2016-03-01
Last updated
2022-06-24

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT02695368. Inclusion in this directory is not an endorsement.